Blackstone Inc. INFORMATION TABLE, Q2 FY2016

Full document

SEC Form 13F Summary: Blackstone Inc.

Business Context and Reporting Period

This filing is a Form 13F Information Table submitted by Blackstone Inc. for the reporting period ending June 30, 2016. The document discloses the equity securities held by the investment manager at the end of the quarter. It does not contain financial statements, revenue data, or operational metrics for Blackstone Inc. itself.

Key Financial Metrics

The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures for Blackstone Inc. Instead, it lists the value and quantity of external securities held in the portfolio. Key portfolio statistics derived from the table include:

  • Top Holding by Value: Hilton Worldwide Holdings Inc. (Value: $452,791,323; Shares: 10,201,389).
  • Top Holding by Share Count: Brixmor Property Group Inc. (Shares: 88,894,497; Value: $2,352,148).
  • Notable Large Positions: Vivint Solar Inc. ($82,359,374), Kosmos Energy Ltd ($96,552,512), Michaels Cos Inc ($55,893,531), and Performance Food Group Co ($46,616,000).
  • Derivatives: The portfolio includes call options (e.g., Valeant Pharmaceuticals) and put options (e.g., SPDR S&P 500 ETF).

Material Changes

The filing text does not provide a prior period comparison or data on material changes in holdings versus the previous quarter. It only presents the snapshot of holdings as of June 30, 2016.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, future guidance, outlook, or specific risk factors. It includes a standard SEC disclaimer stating that the Commission has not reviewed the information for accuracy or completeness.

Investor Verification Checklist

  • Verify the total aggregate value of the portfolio by summing the "Value" column, as the filing does not provide a total.
  • Confirm the voting authority status (Sole, Shared, or None) for specific large positions like Hilton Worldwide and Brixmor Property Group.
  • Review the "Put/Call" column to identify derivative exposure, specifically the call position in Valeant Pharmaceuticals and put positions in SPDR ETFs.
  • Check for any "Other" voting authority designations (OTR) which may indicate complex ownership structures.